Xiongshao Zhitong Recipe Attenuates Nitroglycerin-Induced Migraine-Like Behaviors via the Inhibition of Inflammation Mediated by Nitric Oxide Synthase.
芎芍止痛方は一酸化窒素合成酵素を介した炎症の抑制によりニトログリセリン誘発性片頭痛様行動を減弱する (機械翻訳の邦題)
記録の確認項目
- 研究デザイン
- その他の原著論文
- 対象
- 未確定
- 出版年
- 2022
- 出典
- doi.org
- 抄録の表示
- 表示あり
- 出版状態
- 訂正あり
- 状態確認日
- 2026/08/17
- 収集日
- 2026/08/03
- 鮮度
- 確認期限内
- 確認段階
- 自動処理
- 記録状態
- 公開
出版状態の注記
出版状態: 訂正あり
Europe PMC relationship metadata: corrected_by.
状態の根拠を見る →日本語要約(機械生成)
片頭痛は世界的な障害原因であり、芎芍止痛方(XZR)の治療効果と機序を検討した。UHPLC-LTQ-Orbitrap MSで62成分を同定し、そのうち15成分が血清中に検出された。ニトログリセリン誘発片頭痛ラットモデルを用いたin vivo実験で、XZRはアロディニアと光過敏を減弱し、鎮痛効果を示した。また、一酸化窒素、5-HT、CGRP、SPの異常レベルを正常化し、マスト細胞脱顆粒やIL-1β、IL-6、TNF-αレベルを低下させた。機序として、三叉神経尾側核と中脳水道周囲灰白質におけるnNOSとiNOSの発現および総NOS活性を阻害し、NF-κBシグナル伝達経路を調節した。さらに、主要成分であるインペラトリンとキサントトキシンはnNOSへの高い結合親和性を示し、LPS刺激PC12細胞でnNOS発現とNF-κB経路を阻害した。XZRはNOSとNF-κB経路の抑制を介した抗炎症作用により片頭痛に有効であり、これらの成分が潜在的な活性成分であることが示された。
この要約は公開抄録のみを根拠にAIが機械的に生成したものです。正確な内容は原文を確認してください。
抄録
Migraine is a major cause of disability worldwide, particularly in young adults and middle-aged women. Xiongshao Zhitong Recipe (XZR) is a traditional Chinese medicine prescription used for treating migraine, but its bioactive components and therapeutic mechanisms remain unclear. We aimed to confirm the therapeutic effect of XZR on migraine and to determine the possible mechanism and bioactive components of XZR. Here, a sensitive UHPLC-LTQ-Orbitrap MS assay was carried out to analyze the ingredients of XZR, and a total of 62 components were identified, including coumarins, phenolic acids, phthalides, flavonoids, and terpenoids; among them, 15 components were identified in the serum samples after XZR treatment. We established a rat model of migraine via nitroglycerin (NTG) injection. The in vivo experiments demonstrated that XZR attenuated allodynia and photophobia in rats with NTG-induced migraine, and XZR also demonstrated analgesic effects. XZR reversed the abnormal levels of nitric oxide, 5-hydroxytryptamine (5-HT), calcitonin gene-related peptide (CGRP), and substance P (SP) to normal levels. XZR also downregulated inflammatory reactions, including mast cell degranulation and serum IL-1β, IL-6, and TNF-α levels. In terms of mechanism, we revealed that XZR treated NTG-induced migraine through the inhibition of neuronal nitric oxide synthase (nNOS) and inducible nitric oxide synthase (iNOS) expression in both the trigeminal nucleus caudalis (TNC) and periaqueductal gray matter (PAG), as well as the total NOS enzyme activity, which regulated the NF-κB signaling pathway. Additionally, imperatorin and xanthotoxin, two major ingredients of XZR, showed a high binding affinity to nNOS (Gly468-Leu616). In vitro, XZR, imperatorin, and xanthotoxin inhibited the nNOS expression and the NF-κB signaling pathway in lipopolysaccharide (LPS)-stimulated PC12 cells. In conclusion, we demonstrated the therapeutic effects of XZR and provided evidence that XZR played a critical anti-inflammatory role by suppressing NOS and NF-κB signaling pathway activation. Imperatorin and xanthotoxin were potential bioactive components of XZR. The findings from this study supported that XZR was a candidate herbal drug for migraine therapy.
DOI 10.3389/fphar.2022.920201
PMID 35928284
原文・出典を見る →